Vimta Labs Limited (VIMTALABS) - Net Assets

Latest as of September 2025: Rs4.16 Billion INR ≈ $45.03 Million USD

Based on the latest financial reports, Vimta Labs Limited (VIMTALABS) has net assets worth Rs4.16 Billion INR (≈ $45.03 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs5.18 Billion ≈ $56.04 Million USD) and total liabilities (Rs1.02 Billion ≈ $11.01 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Vimta Labs Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets Rs4.16 Billion
% of Total Assets 80.36%
Annual Growth Rate 6.36%
5-Year Change 94.9%
10-Year Change 200.43%
Growth Volatility 8.31

Vimta Labs Limited - Net Assets Trend (2006–2025)

This chart illustrates how Vimta Labs Limited's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Vimta Labs Limited for the complete picture of this company's asset base.

Annual Net Assets for Vimta Labs Limited (2006–2025)

The table below shows the annual net assets of Vimta Labs Limited from 2006 to 2025. For live valuation and market cap data, see Vimta Labs Limited market cap and net worth.

Year Net Assets Change
2025-03-31 Rs3.79 Billion
≈ $40.97 Million		 +18.50%
2024-03-31 Rs3.20 Billion
≈ $34.57 Million		 +13.45%
2023-03-31 Rs2.82 Billion
≈ $30.47 Million		 +20.43%
2022-03-31 Rs2.34 Billion
≈ $25.30 Million		 +20.37%
2021-03-31 Rs1.94 Billion
≈ $21.02 Million		 +12.44%
2020-03-31 Rs1.73 Billion
≈ $18.70 Million		 +0.77%
2019-03-31 Rs1.72 Billion
≈ $18.55 Million		 +12.82%
2018-03-31 Rs1.52 Billion
≈ $16.44 Million		 +11.68%
2017-03-31 Rs1.36 Billion
≈ $14.72 Million		 +7.97%
2016-03-31 Rs1.26 Billion
≈ $13.64 Million		 +3.08%
2015-03-31 Rs1.22 Billion
≈ $13.23 Million		 +1.61%
2014-03-31 Rs1.20 Billion
≈ $13.02 Million		 +7.18%
2013-03-31 Rs1.12 Billion
≈ $12.15 Million		 +2.44%
2012-03-31 Rs1.10 Billion
≈ $11.86 Million		 -12.30%
2011-03-31 Rs1.25 Billion
≈ $13.52 Million		 -4.36%
2010-03-31 Rs1.31 Billion
≈ $14.14 Million		 +0.45%
2009-03-31 Rs1.30 Billion
≈ $14.07 Million		 +1.54%
2008-03-31 Rs1.28 Billion
≈ $13.86 Million		 +3.37%
2007-03-31 Rs1.24 Billion
≈ $13.41 Million		 +5.68%
2006-03-31 Rs1.17 Billion
≈ $12.69 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Vimta Labs Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 280160000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component Amount Percentage
Retained Earnings Rs2.80 Billion 73.95%
Common Stock Rs44.47 Million 1.17%
Other Comprehensive Income Rs132.00 Million 3.48%
Other Components Rs810.41 Million 21.39%
Total Equity Rs3.79 Billion 100.00%

Vimta Labs Limited Competitors by Market Cap

The table below lists competitors of Vimta Labs Limited ranked by their market capitalization.

Company Market Cap
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class B
IS:KRDMB
 $247.25 Million
Fujian Sanmu Group Co Ltd
SHE:000632
 $247.28 Million
Profound Medical Corp
TO:PRN
 $247.31 Million
Huuuge Inc.
WAR:HUG
 $247.33 Million
Dolly Varden Silver Corporation
V:DV
 $247.21 Million
IMC S.A.
F:IM4
 $247.08 Million
Rani Zim Shopping Centers
TA:RANI
 $247.08 Million
Armada Acquisition Corp. II
NASDAQ:XRPN
 $247.06 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Vimta Labs Limited's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 3,196,960,000 to 3,788,480,000, a change of 591,520,000 (18.5%).
  • Net income of 673,420,000 contributed positively to equity growth.
  • Dividend payments of 44,340,000 reduced retained earnings.
  • Share repurchases of 130,000 reduced equity.
  • New share issuances of 130,000 increased equity.
  • Other comprehensive income decreased equity by 389,999.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Rs673.42 Million +17.78%
Dividends Paid Rs44.34 Million -1.17%
Share Repurchases Rs130.00K -0.0%
Share Issuances Rs130.00K +0.0%
Other Comprehensive Income Rs-390.00K -0.01%
Other Changes Rs-37.17 Million -0.98%
Total Change Rs- 18.50%

Book Value vs Market Value Analysis

This analysis compares Vimta Labs Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.01x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 9.65x to 3.01x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-03-31 Rs53.07 Rs512.20 x
2007-03-31 Rs56.08 Rs512.20 x
2008-03-31 Rs57.97 Rs512.20 x
2009-03-31 Rs58.86 Rs512.20 x
2010-03-31 Rs59.13 Rs512.20 x
2011-03-31 Rs56.55 Rs512.20 x
2012-03-31 Rs49.60 Rs512.20 x
2013-03-31 Rs50.81 Rs512.20 x
2014-03-31 Rs54.45 Rs512.20 x
2015-03-31 Rs55.33 Rs512.20 x
2016-03-31 Rs57.04 Rs512.20 x
2017-03-31 Rs61.58 Rs512.20 x
2018-03-31 Rs68.78 Rs512.20 x
2019-03-31 Rs77.60 Rs512.20 x
2020-03-31 Rs78.20 Rs512.20 x
2021-03-31 Rs87.92 Rs512.20 x
2022-03-31 Rs103.72 Rs512.20 x
2023-03-31 Rs124.89 Rs512.20 x
2024-03-31 Rs142.22 Rs512.20 x
2025-03-31 Rs170.35 Rs512.20 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Vimta Labs Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 17.78%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 19.58%
  • • Asset Turnover: 0.74x
  • • Equity Multiplier: 1.23x
  • Recent ROE (17.78%) is above the historical average (7.42%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 11.51% 24.91% 0.32x 1.46x Rs17.67 Million
2007 7.04% 15.24% 0.33x 1.40x Rs-36.71 Million
2008 4.87% 8.14% 0.44x 1.35x Rs-65.70 Million
2009 3.11% 4.96% 0.48x 1.30x Rs-89.69 Million
2010 2.03% 3.06% 0.48x 1.39x Rs-104.14 Million
2011 -3.73% -4.87% 0.54x 1.41x Rs-171.68 Million
2012 -14.02% -17.60% 0.56x 1.43x Rs-263.41 Million
2013 3.75% 3.86% 0.75x 1.29x Rs-70.19 Million
2014 11.00% 11.19% 0.79x 1.24x Rs12.01 Million
2015 4.14% 4.72% 0.73x 1.20x Rs-71.71 Million
2016 5.10% 5.16% 0.71x 1.39x Rs-61.76 Million
2017 7.78% 6.88% 0.69x 1.63x Rs-30.23 Million
2018 10.81% 8.96% 0.79x 1.53x Rs12.28 Million
2019 14.75% 11.90% 0.90x 1.38x Rs81.56 Million
2020 3.96% 3.79% 0.74x 1.42x Rs-104.43 Million
2021 11.01% 10.26% 0.76x 1.41x Rs19.67 Million
2022 17.66% 14.98% 0.90x 1.31x Rs179.32 Million
2023 17.10% 15.29% 0.87x 1.29x Rs199.93 Million
2024 12.83% 12.89% 0.80x 1.25x Rs90.39 Million
2025 17.78% 19.58% 0.74x 1.23x Rs294.57 Million

Industry Comparison

This section compares Vimta Labs Limited's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

  • Industry: Diagnostics & Research
  • Average net assets among peers: $4,925,401,610
  • Average return on equity (ROE) among peers: 14.79%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Vimta Labs Limited (VIMTALABS) Rs4.16 Billion 11.51% 0.24x $247.25 Million
Krsnaa Diagnostics Limited (KRSNAA) $-228.96 Million 0.00% 0.00x $210.31 Million
Dr. Lal Path Labs Ltd. (LALPATHLAB) $5.10 Billion 25.94% 0.23x $2.98 Billion
Metropolis Healthcare Limited (METROPOLIS) $13.35 Billion 10.86% 0.40x $308.02 Million
Syngene International Limited (SYNGENE) $2.21 Billion 12.32% 1.28x $1.99 Billion
Thyrocare Technologies Limited (THYROCARE) $3.67 Billion 24.11% 0.28x $837.40 Million
Vijaya Diagnostic Centre Limited (VIJAYA) $5.47 Billion 15.48% 0.56x $1.42 Billion

About Vimta Labs Limited

NSE:VIMTALABS India Diagnostics & Research
Market Cap
$247.25 Million
Rs22.86 Billion INR
Market Cap Rank
#15761 Global
#795 in India
Share Price
Rs512.20
Change (1 day)
+1.19%
52-Week Range
Rs380.70 - Rs1071.90
All Time High
Rs1155.00
Categories
Companies in India Diagnostics & Research
About

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract researc… Read more